These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 22626600)

  • 1. Allergen immunotherapy practice patterns: a worldwide survey.
    Ponda P; Mithani S; Kopyltsova Y; Sison C; Gupta P; Larenas D; Bonagura VR
    Ann Allergy Asthma Immunol; 2012 Jun; 108(6):454-459.e7. PubMed ID: 22626600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survey on immunotherapy practice patterns: dose, dose adjustments, and duration.
    Larenas-Linnemann DE; Gupta P; Mithani S; Ponda P
    Ann Allergy Asthma Immunol; 2012 May; 108(5):373-378.e3. PubMed ID: 22541411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perception and practice of sublingual immunotherapy among practicing allergists.
    Tucker MH; Tankersley MS;
    Ann Allergy Asthma Immunol; 2008 Oct; 101(4):419-25. PubMed ID: 18939732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of standardized extracts in allergen immunotherapy.
    Nelson HS
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):41-5. PubMed ID: 10887303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of allergen immunotherapy practice patterns in the United States and Europe.
    Cox L; Jacobsen L
    Ann Allergy Asthma Immunol; 2009 Dec; 103(6):451-59; quiz 459-61, 495. PubMed ID: 20084837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma.
    Roberts G; Hurley C; Turcanu V; Lack G
    J Allergy Clin Immunol; 2006 Feb; 117(2):263-8. PubMed ID: 16461125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cry j 1-induced synthesis of interleukin-5 and interferon-gamma by peripheral blood mononuclear cells of patients with seasonal allergic rhinitis due to Japanese cedar pollens.
    Nakai Y; Ohashi Y; Tanaka A; Kakinoki Y; Washio Y; Masamoto T; Yamada K; Nakai Y; Ohmoto Y
    Acta Otolaryngol Suppl; 1998; 538():143-51. PubMed ID: 9879414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose adjustment practices among allergists for local reactions to immunotherapy.
    Coop CA; Tankersley MS
    Ann Allergy Asthma Immunol; 2007 Jul; 99(1):77-81. PubMed ID: 17650834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rush sublingual immunotherapy in Parietaria allergic patients.
    D'Ambrosio FP; Ricciardi L; Isola S; Savi E; Parmiani S; Puccinelli P; Musarra A
    Allergol Immunopathol (Madr); 1996; 24(4):146-51. PubMed ID: 8939269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosing and efficacy in specific immunotherapy.
    Demoly P; Calderon MA
    Allergy; 2011 Jul; 66 Suppl 95():38-40. PubMed ID: 21668851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals.
    TePas EC; Hoyte EG; McIntire JJ; Umetsu DT
    Ann Allergy Asthma Immunol; 2004 Jan; 92(1):25-31. PubMed ID: 14756461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of allergen immunotherapy practice parameters on cat extract prescribing patterns, 1993-2009.
    Robertson BD; McCoy RL; Nelson MR; Haymore BR
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):437-40. PubMed ID: 22018616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rush immunotherapy with sublingual administration of grass allergen extract.
    Feliziani V; Marfisi RM; Parmiani S
    Allergol Immunopathol (Madr); 1993; 21(5):173-8. PubMed ID: 8160561
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
    Ariano R; Panzani RC; Mistrello G
    Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes.
    Cox L; Esch RE; Corbett M; Hankin C; Nelson M; Plunkett G
    Ann Allergy Asthma Immunol; 2011 Oct; 107(4):289-99; quiz 300. PubMed ID: 21962088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preventive immunotherapy].
    Boquete M; Carballada F; Expósito F; González A
    Allergol Immunopathol (Madr); 2000; 28(3):89-93. PubMed ID: 10867376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for fatal and nonfatal reactions to subcutaneous immunotherapy: National surveillance study on allergen immunotherapy (2008-2013).
    Epstein TG; Liss GM; Murphy-Berendts K; Bernstein DI
    Ann Allergy Asthma Immunol; 2016 Apr; 116(4):354-359.e2. PubMed ID: 26948485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.
    Reich K; Gessner C; Kroker A; Schwab JA; Pohl W; Villesen H; Wüstenberg E; Emminger W
    Clin Ther; 2011 Jul; 33(7):828-40. PubMed ID: 21741092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
    Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.